Evaluation of Hypertriglyceridemia in Critically Ill Patients With Coronavirus Disease 2019 Receiving Propofol
Objectives:. To report the prevalence of, and evaluate risk factors for, the development of hypertriglyceridemia (defined as a serum triglyceride level of > 400 mg/dL) in patients with coronavirus disease 2019 who received propofol. Design:. Single-center, retrospective, observational analysis. S...
| Published in: | Critical Care Explorations |
|---|---|
| Main Authors: | Mary P. Kovacevic, PharmD, BCCCP, BCPS, Kevin M. Dube, PharmD, BCCCP, BCPS, Kenneth E. Lupi, PharmD, BCCCP, BCPS, Paul M. Szumita, PharmD, FCCM, FASHP, BCCCP, BCPS, Jeremy R. DeGrado, PharmD, BCCCP, BCPS |
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer
2021-01-01
|
| Online Access: | http://journals.lww.com/10.1097/CCE.0000000000000330 |
Similar Items
A Retrospective, Single-Center Assessment of Changes in Pain, Agitation, and Delirium Management Before and During the COVID-19 Pandemic
by: Rachel L. Winner, PharmD, BCCCP, et al.
Published: (2025-01-01)
by: Rachel L. Winner, PharmD, BCCCP, et al.
Published: (2025-01-01)
Practices and Outcomes Associated With Sublingual Buprenorphine Use in a Critically Ill Population
by: Denis J. Vanini, PharmD, BCCCP, et al.
Published: (2024-03-01)
by: Denis J. Vanini, PharmD, BCCCP, et al.
Published: (2024-03-01)
Optimizing Pharmacist Team-Integration for ICU Patient Management: Rationale, Study Design, and Methods for a Multicentered Exploration of Pharmacist-to-Patient Ratio
by: Kelli Keats, PharmD, MPA, BCCCP, et al.
Published: (2023-09-01)
by: Kelli Keats, PharmD, MPA, BCCCP, et al.
Published: (2023-09-01)
Prevalence and Risk Factors for Iatrogenic Opioid Withdrawal in Medical Critical Care Patients
by: Marlena A. Fox, PharmD, BCPS, BCCCP, et al.
Published: (2023-05-01)
by: Marlena A. Fox, PharmD, BCPS, BCCCP, et al.
Published: (2023-05-01)
Precipitated withdrawal with kratom use following naltrexone administration
by: Jarka Courtney PharmD, BCPS, BCPP, et al.
Published: (2023-06-01)
by: Jarka Courtney PharmD, BCPS, BCPP, et al.
Published: (2023-06-01)
Evaluating the impact of an emergency department protocol that guides management of methamphetamine-induced agitation and psychosis
by: Julie Nguyen, PharmD, et al.
Published: (2022-01-01)
by: Julie Nguyen, PharmD, et al.
Published: (2022-01-01)
FARMACÉUTICOS CLÍNICOS: PROFESIONALES ESENCIALES DEL EQUIPO DE ATENCIÓN CLÍNICA
by: Judith Jacobi, PharmD, ACCP, MCCM, BCPS, BCCCP
Published: (2016-09-01)
by: Judith Jacobi, PharmD, ACCP, MCCM, BCPS, BCCCP
Published: (2016-09-01)
A Review of Pulmonary Arterial Hypertension Treatment in Extracorporeal Membrane Oxygenation: A Case Series of Adult Patients
by: Heather Torbic PharmD, BCPS, BCCCP, et al.
Published: (2022-01-01)
by: Heather Torbic PharmD, BCPS, BCCCP, et al.
Published: (2022-01-01)
Major Publications in the Critical Care Pharmacotherapy Literature: 2020
by: Brittany D. Bissell, PharmD, PhD, BCCCP, et al.
Published: (2021-12-01)
by: Brittany D. Bissell, PharmD, PhD, BCCCP, et al.
Published: (2021-12-01)
Coagulation Factor Xa (Recombinant), Inactivated-Zhzo (Andexanet Alfa) Hemostatic Outcomes and Thrombotic Event Incidence at an Academic Medical Center
by: Victoria M. Stevens PharmD, et al.
Published: (2019-12-01)
by: Victoria M. Stevens PharmD, et al.
Published: (2019-12-01)
Serotonin syndrome and neuroleptic malignant syndrome: A case report of intersecting symptomatology
by: Loulwa Maktabi, PharmD, BCPS, et al.
Published: (2024-02-01)
by: Loulwa Maktabi, PharmD, BCPS, et al.
Published: (2024-02-01)
A Review and Clinical Understanding of Tenofovir: Tenofovir Disoproxil Fumarate versus Tenofovir Alafenamide
by: Chanie Wassner PharmD, BCCCP, BCIDP, et al.
Published: (2020-04-01)
by: Chanie Wassner PharmD, BCCCP, BCIDP, et al.
Published: (2020-04-01)
Thromboprophylaxis in Hospitalized Non-Critically Ill Patients With Mild-to-Moderate COVID-19 Infection: A Systematic Review
and Meta-Analysis
by: Awatif Hafiz PharmD, BCCP, et al.
Published: (2023-08-01)
by: Awatif Hafiz PharmD, BCCP, et al.
Published: (2023-08-01)
Sotatercept for Pulmonary Arterial Hypertension in the Inpatient Setting
by: Heather Torbic PharmD, FCCM, BCPS, BCCCP, et al.
Published: (2024-02-01)
by: Heather Torbic PharmD, FCCM, BCPS, BCCCP, et al.
Published: (2024-02-01)
Clinical outcomes for patients on antiplatelet and anticoagulants in thoracoabdominal trauma
by: Victoria Sharp, DO, FACS, FACOS, et al.
Published: (2023-12-01)
by: Victoria Sharp, DO, FACS, FACOS, et al.
Published: (2023-12-01)
Evaluation of Hydrocortisone Discontinuation Strategies in Septic Shock: A Retrospective Cohort Study
by: Hanine O. AlMubayedh, PharmD, BCPS, BCCCP, et al.
Published: (2025-07-01)
by: Hanine O. AlMubayedh, PharmD, BCPS, BCCCP, et al.
Published: (2025-07-01)
Fibrinogen Concentrate for the Treatment of Thrombolysis-Associated Hemorrhage in Adult Ischemic Stroke Patients
by: Megan E. Barra PharmD, BCPS, BCCCP, et al.
Published: (2020-09-01)
by: Megan E. Barra PharmD, BCPS, BCCCP, et al.
Published: (2020-09-01)
Formulary Reconciliation: Implementation of a Comprehensive Approach to Formulary Maintenance and Standardization
by: Janine G. Martino PharmD, BCOP, APh, et al.
Published: (2024-08-01)
by: Janine G. Martino PharmD, BCOP, APh, et al.
Published: (2024-08-01)
Ketamine for Primary Analgosedation in Critically Ill Surgery and Trauma Patients Requiring Mechanical Ventilation
by: Bradley J. Peters, PharmD, BCPS, BCCCP, et al.
Published: (2024-02-01)
by: Bradley J. Peters, PharmD, BCPS, BCCCP, et al.
Published: (2024-02-01)
Characterization of hospitalized patients who received naloxone while receiving opioids with or without gabapentinoids
by: Payal H. Desai, PharmD, BCCCP, et al.
Published: (2021-07-01)
by: Payal H. Desai, PharmD, BCCCP, et al.
Published: (2021-07-01)
Characterizing Critical Care Pharmacy Services Across the United States
by: Robert MacLaren, PharmD, MPH, FCCM, FCCP, et al.
Published: (2021-01-01)
by: Robert MacLaren, PharmD, MPH, FCCM, FCCP, et al.
Published: (2021-01-01)
A retrospective review of intramuscular olanzapine and parenteral benzodiazepine coadministration in the emergency department
by: Jessica Laub, PharmD, BCEMP, et al.
Published: (2024-08-01)
by: Jessica Laub, PharmD, BCEMP, et al.
Published: (2024-08-01)
Offering a combined resident research training program and pharmacy student elective may help improve resident publication rates
by: Brown Geoffrey PharmD, et al.
Published: (2023-08-01)
by: Brown Geoffrey PharmD, et al.
Published: (2023-08-01)
Enteral Administration of Twice-Daily Dolutegravir and Rilpivirine as a Part of a Triple-Therapy Regimen in a Critically Ill Patient with HIV
by: Sarah Lynn Turley PharmD, BCPS, et al.
Published: (2017-03-01)
by: Sarah Lynn Turley PharmD, BCPS, et al.
Published: (2017-03-01)
Hyperammonemia in patients receiving valproic acid in the hospital setting: A retrospective review
by: Tressa McMorris, PharmD, BCPS, et al.
Published: (2021-07-01)
by: Tressa McMorris, PharmD, BCPS, et al.
Published: (2021-07-01)
Evaluation of Rivaroxaban Exposure via
Anti-Xa Levels During VTE Prophylaxis
in Hospitalized Patients
by: Kaitlin Blotske PharmD, et al.
Published: (2025-02-01)
by: Kaitlin Blotske PharmD, et al.
Published: (2025-02-01)
Evaluation of drug-drug interactions in hospitalized patients on medications for OUD
by: Olivia Berger, PharmD, et al.
Published: (2021-07-01)
by: Olivia Berger, PharmD, et al.
Published: (2021-07-01)
Impact of marketing to improve patient access to care and clinic utilization for clinical pharmacy specialists
by: Nora Bairagdar, PharmD, BCPS, et al.
Published: (2023-03-01)
by: Nora Bairagdar, PharmD, BCPS, et al.
Published: (2023-03-01)
Social Media and Unprofessional Pharmacist Conduct: A Cross-Sectional Survey of Boards of Pharmacy
by: Lindsey Elmore, PharmD, BCPS, et al.
Published: (2013-01-01)
by: Lindsey Elmore, PharmD, BCPS, et al.
Published: (2013-01-01)
Venous Thromboembolism Prophylaxis with Enoxaparin Versus Unfractionated Heparin in Patients with Low Body Weight
by: David Michael Kaylor PharmD, et al.
Published: (2023-02-01)
by: David Michael Kaylor PharmD, et al.
Published: (2023-02-01)
Record Setting Temperatures in the Setting of SARS-CoV-2 Suggests Dexmedetomidine Drug-Induced Fever: A Case Report
by: Megan Meier PharmD, BCPS, et al.
Published: (2024-06-01)
by: Megan Meier PharmD, BCPS, et al.
Published: (2024-06-01)
Pharmacist impact on medication reconciliation of behavioral health patients boarding in the emergency department
by: Mary Accomando, PharmD, BCPP, et al.
Published: (2022-06-01)
by: Mary Accomando, PharmD, BCPP, et al.
Published: (2022-06-01)
Impact of Vitamin K Administration on Elevated International Normalized Ratio in Chronic Liver Disease
by: Carmen B. Smith PharmD, BCPS, et al.
Published: (2023-04-01)
by: Carmen B. Smith PharmD, BCPS, et al.
Published: (2023-04-01)
Comparison of droperidol and haloperidol for acute agitation in the emergency department: A retrospective cohort study
by: Francesca DiGuglielmo, PharmD, et al.
Published: (2025-10-01)
by: Francesca DiGuglielmo, PharmD, et al.
Published: (2025-10-01)
Differentiating probable nitrofurantoin-induced drug fever from antipsychotic-induced hyperthermia in a patient receiving clozapine
by: Stephen B. Vickery, PharmD, BCPS, et al.
Published: (2022-06-01)
by: Stephen B. Vickery, PharmD, BCPS, et al.
Published: (2022-06-01)
Development and implementation of a physician-pharmacist collaborative practice model for provision and management of buprenorphine/naloxone
by: Lindsay M. Mailloux, PharmD, et al.
Published: (2021-01-01)
by: Lindsay M. Mailloux, PharmD, et al.
Published: (2021-01-01)
Procalcitonin-Guided Management and Duration of Antibiotic Therapy in Critically Ill Cancer Patients With Sepsis (Pro-Can Study): A Randomized Controlled Trial
by: Lama H. Nazer, PharmD, BCPS, FCCM, et al.
Published: (2024-10-01)
by: Lama H. Nazer, PharmD, BCPS, FCCM, et al.
Published: (2024-10-01)
Knowledge and attitude of Lebanese women about cosmetics: a cross-sectional survey
by: Bahia Chahine, RPh, PharmD, MSc, BCPS, et al.
Published: (2023-10-01)
by: Bahia Chahine, RPh, PharmD, MSc, BCPS, et al.
Published: (2023-10-01)
Management of Hypertriglyceridemia-Induced Acute Pancreatitis in a Nondiabetic Patient
by: Jamie M. Reed, PharmD, BCPS, et al.
Published: (2021-02-01)
by: Jamie M. Reed, PharmD, BCPS, et al.
Published: (2021-02-01)
Evaluation of the use of chlorpromazine for agitation in pediatric patients
by: Rajwoana Ahmed, PharmD, et al.
Published: (2023-03-01)
by: Rajwoana Ahmed, PharmD, et al.
Published: (2023-03-01)
Similar Items
-
A Retrospective, Single-Center Assessment of Changes in Pain, Agitation, and Delirium Management Before and During the COVID-19 Pandemic
by: Rachel L. Winner, PharmD, BCCCP, et al.
Published: (2025-01-01) -
Practices and Outcomes Associated With Sublingual Buprenorphine Use in a Critically Ill Population
by: Denis J. Vanini, PharmD, BCCCP, et al.
Published: (2024-03-01) -
Optimizing Pharmacist Team-Integration for ICU Patient Management: Rationale, Study Design, and Methods for a Multicentered Exploration of Pharmacist-to-Patient Ratio
by: Kelli Keats, PharmD, MPA, BCCCP, et al.
Published: (2023-09-01) -
Prevalence and Risk Factors for Iatrogenic Opioid Withdrawal in Medical Critical Care Patients
by: Marlena A. Fox, PharmD, BCPS, BCCCP, et al.
Published: (2023-05-01) -
Precipitated withdrawal with kratom use following naltrexone administration
by: Jarka Courtney PharmD, BCPS, BCPP, et al.
Published: (2023-06-01)
